{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:55:45Z","timestamp":1791147345807,"version":"4.1.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jcrsjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.jcrs.2015.02.034","type":"journal-article","created":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T13:53:32Z","timestamp":1437573212000},"page":"1484-1489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Erufosine, a phosphoinositide-3-kinase inhibitor, to mitigate posterior capsule opacification in the human capsular bag model"],"prefix":"10.1097","volume":"41","author":[{"given":"Christian","family":"Wertheimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Brandlhuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang J.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Laubichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anselm","family":"Kampik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Eibl-Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-23-20210210","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jcrs.2008.11.044","article-title":"Posterior capsule opacification and neodymium:YAG laser capsulotomy rates with a round-edged silicone and a sharp-edged hydrophobic acrylic intraocular lens 10 years after surgery.","volume":"35","author":"Vock","year":"2009","journal-title":"J Cataract Refract Surg"},{"key":"R5-23-20210210","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.jcrs.2012.04.040","article-title":"Prevention of capsular bag opacification with a modified hydrophilic acrylic disk-shaped intraocular lens.","volume":"38","author":"Leishman","year":"2012","journal-title":"J Cataract Refract Surg"},{"key":"R6-23-20210210","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jcrs.2012.09.028","article-title":"Alkylphosphocholines for intraocular lens coating.","volume":"39","author":"Eibl","year":"2013","journal-title":"J Cataract Refract Surg"},{"key":"R7-23-20210210","first-page":"990","article-title":"Intraokularlinse als Medikamententrager.","volume":"110","author":"Eibl-Lindner","year":"2013","journal-title":"Intraocular lens as a drug delivery device, Ophthalmologe"},{"key":"R8-23-20210210","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1089\/jop.2012.0062","article-title":"Hydrophilic acrylic intraocular lens as a drug delivery system: influence of the presoaking time and comparison to intracameral injection.","volume":"29","author":"Lipnitzki","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"key":"R9-23-20210210","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3109\/02713683.2014.888453","article-title":"EGFR-blockade with erlotinib reduces EGF and TGF-2 expression and the actin-cytoskeleton which influences different aspects of cellular migration in lens epithelial cells.","volume":"39","author":"Wertheimer","year":"2014","journal-title":"Curr Eye Res"},{"key":"R10-23-20210210","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00417-013-2257-z","article-title":"EGF receptor inhibitor erlotinib as a potential pharmacological prophylaxis for posterior capsule opacification.","volume":"251","author":"Wertheimer","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R11-23-20210210","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00417-013-2524-z","article-title":"Attenuation of human lens epithelial cell spreading, migration and contraction via downregulation of the PI3KAkt pathway.","volume":"252","author":"Liegl","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R12-23-20210210","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jcrs.2008.11.064","article-title":"Alkylphosphocholines as a potential pharmacologic prophylaxis for posterior capsule opacification.","volume":"35","author":"Eibl","year":"2009","journal-title":"J Cataract Refract Surg"},{"key":"R15-23-20210210","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/exer.2001.1153","article-title":"Posterior capsule opacification: a cell biological perspective.","volume":"74","author":"Wormstone","year":"2002","journal-title":"Exp Eye Res"},{"key":"R17-23-20210210","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00417-008-1007-0","article-title":"Polylactide-glycoli acid and rapamycin coating intraocular lens prevent posterior capsular opacification in rabbit eyes.","volume":"247","author":"Liu","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R19-23-20210210","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00417-014-2656-9","article-title":"Comparison of posterior capsule opacification in rabbit eyes receiving different administrations of rapamycin.","volume":"252","author":"Liu","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R20-23-20210210","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1442-9071.2009.01921.x","article-title":"Pharmacological attempts to reduce posterior capsule opacification after cataract surgery - a review.","volume":"36","author":"Walker","year":"2008","journal-title":"Clin Exp Ophthalmol"},{"key":"R21-23-20210210","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.etap.2005.07.012","article-title":"A focus on the human lens in vitro.","volume":"21","author":"Wormstone","year":"2006","journal-title":"Environ Toxicol Pharmacol"},{"key":"R23-23-20210210","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.exer.2008.10.016","article-title":"Posterior capsule opacification.","volume":"88","author":"Wormstone","year":"2009","journal-title":"Exp Eye Res"},{"key":"R24-23-20210210","doi-asserted-by":"crossref","first-page":"7057","DOI":"10.1167\/iovs.14-15302","article-title":"An in vitro evaluation of the Anew Zephyr open bag IOL in the prevention of posterior capsule opacification using a human capsular bag model.","volume":"55","author":"Eldred","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R25-23-20210210","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/nm0997-1026","article-title":"Thapsigargin-coated intraocular lenses inhibit human lens cell growth.","volume":"3","author":"Duncan","year":"1997","journal-title":"Nat Med"},{"key":"R26-23-20210210","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/jgs.12794","article-title":"Patterns of surgical care and complications in elderly adults.","volume":"62","author":"Deiner","year":"2014","journal-title":"J Am Geriatr Soc"},{"key":"R29-23-20210210","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.jcrs.2013.11.043","article-title":"Intraindividual aqueous flare comparison after implantation of hydrophobic intraocular lenses with or without a heparin-coated surface.","volume":"40","author":"Krall","year":"2014","journal-title":"J Cataract Refract Surg"},{"key":"R33-23-20210210","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0886-3350(13)80142-3","article-title":"Correlations between aqueous flare and cells and lens surface cytology in eyes with poly(methyl methacrylate) and heparin-surface-modified intraocular lenses.","volume":"21","author":"Pande","year":"1995","journal-title":"J Cataract Refract Surg"},{"key":"R34-23-20210210","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/archopht.1991.01080120065027","article-title":"Role of interleukin 6 in the inflammatory response after cataract surgery; an experimental and clinical study.","volume":"109","author":"Malecaze","year":"1991","journal-title":"Arch Ophthalmol"}],"container-title":["Journal of Cataract and Refractive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335015006689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335015006689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1016\/j.jcrs.2015.02.034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T18:21:06Z","timestamp":1623781266000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/02158034-201507000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jcrs.2015.02.034","relation":{},"ISSN":["0886-3350"],"issn-type":[{"value":"0886-3350","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erufosine, a phosphoinositide-3-kinase inhibitor, to mitigate posterior capsule opacification in the human capsular bag model","name":"articletitle","label":"Article Title"},{"value":"Journal of Cataract & Refractive Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrs.2015.02.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}